The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells-Reference-Cited by-同舟云学术

The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells

Published:2017-05-02 Issue:6 Volume:65 Page:2031-2044
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Vilaseca Marina¹²,García-Calderó Héctor¹³,Lafoz Erica¹²,García-Irigoyen Oihane³⁴,Avila Matías A.³⁴,Reverter Joan Carles⁵,Bosch Jaume¹²³⁶,Hernández-Gea Virginia¹³,Gracia-Sancho Jordi¹²³^ORCID,García-Pagán Joan Carles¹²³

Affiliation:

1. Barcelona Hepatic Hemodynamic Lab, Liver Unit, Hospital Clínic, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); Spain

2. University of Barcelona Medical School; Barcelona Spain

3. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD); Spain

4. Centro de Investigación Médica Aplicada (CIMA); Division of Hepatology; University of Navarra, IDISNA (Instituto de Investigacion Sanitaria de Navarra); Pamplona Spain

5. Hemotherapy and Hemostasis Department; Hospital Clínic; Barcelona Spain

6. Swiss Liver Centre, Inselspital; Bern University; Switzerland

Funder

Ministerio de Economía y Competitividad

Instituto de Salud Carlos III

European Union (Fondos FEDER, “una manera de hacer Europa”)

Publisher

Wiley

Subject

Hepatology

Reference37 articles.

1. Complications of cirrhosis. I. Portal hypertension;Bosch;J Hepatol,2000